Identification of potential peripheral blood diagnostic biomarkers for patients with juvenile idiopathic arthritis by

Zhi-Qiang Tu1, Hai-Yan Xue1, Wei Chen1

  • 1Department of Pediatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, 145 Shandongzhong Road, Shanghai, 200001, China.

Rheumatology International
|November 21, 2016
PubMed

Insights

Juvenile idiopathic arthritis (JIA) diagnosis lacks effective biomarkers. This study developed a predictive model using gene expression and signaling pathways, offering potential diagnostic and therapeutic targets for JIA.

Area of Science:

  • Rheumatology
  • Pediatric Medicine
  • Bioinformatics

Background:

  • Juvenile idiopathic arthritis (JIA) is a prevalent childhood rheumatic disease with significant health impacts.
  • Current diagnostic methods for JIA often lack effective early-onset biomarkers.
  • Identifying reliable biomarkers is crucial for timely diagnosis and management of JIA.

Purpose of the Study:

  • To construct a robust classification model for predicting JIA.
  • To identify potential gene expression biomarkers and signaling pathways associated with JIA.
  • To explore the pathogenic mechanisms underlying JIA through bioinformatics analysis.

Main Methods:

  • Downloaded peripheral blood gene expression profile data from the GEO database.
  • Analyzed differentially expressed genes (DEGs) using Pearson's correlation and unsupervised clustering.
  • Constructed co-expression networks and identified enriched signaling pathways (e.g., B/T cell receptor, ErbB, MAPK).

Main Results:

  • Identified eighteen specific correlated DEGs with altered correlations across disease states.
  • Developed a classification model utilizing eight significantly enriched signaling pathways.
  • Achieved high accuracy in predicting JIA using the developed classification model.

Conclusions:

  • The developed classification model demonstrates high accuracy in predicting JIA.
  • Specific gene sets and enriched signaling pathways show potential as biomarkers for JIA diagnosis.
  • Findings offer insights into JIA pathogenesis and potential therapeutic targets.